Furthermore, by analyzing patient tumor samples, the researchers discovered that the increased expression of IL-1β in primary tumors was strongly correlated with adverse clinical outcomes and a significantly increased likelihood of developing bone metastasis [57]. Here, IL1B is linked to neoplasm.